Baird Maintains Certara(CERT.US) With Hold Rating, Cuts Target Price to $13
United States Medical Writing Market Report 2024-2032, Featuring Profiles of Inclin, Parexel, Cardinal Health, MakroCare, Freyr Solutions, Banner Medical, IQVIA Holdings, Certara and Clinovo
Baird Maintains Neutral on Certara, Lowers Price Target to $13
Earnings Preview: Certara to Report Financial Results Post-market on November 06
$Certara(CERT.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Certara(CERT.US)$ to post revenue of USD95.60M for 2024Q3, up 11.71%
Certara to Participate in the Stephens Annual Investment Conference
Certara, Inc. (NASDAQ:CERT) Shares Could Be 23% Above Their Intrinsic Value Estimate